Can a rheumatoid arthritis drug reach childhood brain tumors?
NCT ID NCT03970226
First seen Feb 19, 2026 · Last updated May 16, 2026 · Updated 11 times
Summary
This early-stage study tests whether the drug tocilizumab can reach craniopharyngioma tumors in children. In the first part, 9 children with new or recurring tumors receive one dose before surgery to see if the drug enters the tumor. If it does, a second part will give the drug every two weeks for up to a year to check safety. The goal is to gather information, not to treat the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADAMANTINOMATOUS CRANIOPHARYNGIOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Children's Hospital Colorado
Aurora, Colorado, 80045, United States
Conditions
Explore the condition pages connected to this study.